Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CollPlant Biotechnologies (CLGN) Free Cash Flow (2018 - 2025)

Historic Free Cash Flow for CollPlant Biotechnologies (CLGN) over the last 8 years, with Q3 2025 value amounting to -$2.9 million.

  • CollPlant Biotechnologies' Free Cash Flow rose 1305.93% to -$2.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$9.9 million, marking a year-over-year increase of 1984.42%. This contributed to the annual value of -$13.6 million for FY2024, which is 65234.94% down from last year.
  • Latest data reveals that CollPlant Biotechnologies reported Free Cash Flow of -$2.9 million as of Q3 2025, which was up 1305.93% from -$2.4 million recorded in Q2 2025.
  • In the past 5 years, CollPlant Biotechnologies' Free Cash Flow ranged from a high of $11.2 million in Q1 2021 and a low of -$12.4 million during Q4 2022
  • In the last 5 years, CollPlant Biotechnologies' Free Cash Flow had a median value of -$2.9 million in 2022 and averaged -$2.0 million.
  • As far as peak fluctuations go, CollPlant Biotechnologies' Free Cash Flow soared by 54964.0% in 2021, and later plummeted by 115241.94% in 2022.
  • Quarter analysis of 5 years shows CollPlant Biotechnologies' Free Cash Flow stood at -$992000.0 in 2021, then crashed by 1152.42% to -$12.4 million in 2022, then skyrocketed by 82.97% to -$2.1 million in 2023, then plummeted by 60.92% to -$3.4 million in 2024, then rose by 15.54% to -$2.9 million in 2025.
  • Its last three reported values are -$2.9 million in Q3 2025, -$2.4 million for Q2 2025, and -$1.2 million during Q1 2025.